| Assisted Daily Living, Inc. | |
| 2809 Post Road, Warwick, Rhode Island 2886 | |
| (401) 738-5470 | |
| Name | Assisted Daily Living, Inc. |
|---|---|
| Location | 2809 Post Road, Warwick, Rhode Island |
| Certified By | Medicare |
| Services Offered | Nursing Care Physical Therapy Occupational Therapy Speech Pathology Medical Social Services Home Health Aide |
| Medicare ID | 417035 |
| Ownership Type | Proprietary |
| Service Area Zip Codes | 2802, 2806, 2809, 2813, 2814, 2816, 2817, 2818, 2822, 2825, 2826, 2828, 2830, 2832, 2838, 2839, 2842, 2852, 2857, 2859, 2860, 2861, 2863, 2864, 2865, 2876, 2879, 2881, 2882, 2885, 2886, 2888, 2889, 2892, 2893, 2895, 2896, 2902, 2903, 2904, 2905, 2906, 2907, 2908, 2909, 2910, 2911, 2914, 2915, 2916, 2917, 2919, 2920, 2921 |
| NPI Number | 1831196955 |
| Organization Name | ASSISTED DAILY LIVING, INC |
| Doing Business As | ELARA CARING |
| Address | 2809 Post Rd, Warwick, RI 02886 |
| Phone Number | 401-738-5470 |
News Archive
"The results of this study are consistent with an American study which found that outdoor sport was protective, however our study shows that the crucial feature is being outdoors irrespective of the activity you are doing."
The Obama administration announced a new policy on Wednesday that will allow many people to renew their existing insurance policies for two more years even though the policies don't provide the comprehensive coverage and consumer protections required by the Affordable Care Act.
Celladon Corp., a biopharmaceutical company focused on the discovery and development of innovative treatments for cardiovascular diseases, today announced that 12-month data from its Phase 2 CUPID clinical trial of MYDICAR demonstrated significant improvements in clinical outcomes and key disease markers in advanced heart failure patients treated with the genetically-targeted enzyme replacement therapy.
RyMed Technologies will host a breakfast symposium on the origin of catheter-related bloodstream infections (CRBSIs) and how to prevent them at the upcoming Annual Scientific Meeting of the Association for Vascular Access (AVA).
› Verified 4 days ago
| Quality Rating: |
News Archive
"The results of this study are consistent with an American study which found that outdoor sport was protective, however our study shows that the crucial feature is being outdoors irrespective of the activity you are doing."
The Obama administration announced a new policy on Wednesday that will allow many people to renew their existing insurance policies for two more years even though the policies don't provide the comprehensive coverage and consumer protections required by the Affordable Care Act.
Celladon Corp., a biopharmaceutical company focused on the discovery and development of innovative treatments for cardiovascular diseases, today announced that 12-month data from its Phase 2 CUPID clinical trial of MYDICAR demonstrated significant improvements in clinical outcomes and key disease markers in advanced heart failure patients treated with the genetically-targeted enzyme replacement therapy.
RyMed Technologies will host a breakfast symposium on the origin of catheter-related bloodstream infections (CRBSIs) and how to prevent them at the upcoming Annual Scientific Meeting of the Association for Vascular Access (AVA).
› Verified 4 days ago
| Quality Measure | Provider | National Avg. |
|---|---|---|
| How often the home health team began their patients’ care in a timely manner | 99.4 | 95.7 |
| How often the home health team taught patients (or their family caregivers) about their drugs | 99.2 | 98.6 |
| How often the home health team checked patients’ risk of falling | 99.3 | 99.6 |
| How often the home health team checked patients for depression | 96.1 | 97.4 |
| How often the home health team made sure that their patients have received a flu shot for the current flu season. | 93.4 | 78.7 |
| How often the home health team made sure that their patients have received a pneumococcal vaccine (pneumonia shot). | 92.5 | 82.2 |
| With diabetes, how often the home health team got doctor’s orders, gave foot care, and taught patients about foot care | 97 | 96.4 |
News Archive
"The results of this study are consistent with an American study which found that outdoor sport was protective, however our study shows that the crucial feature is being outdoors irrespective of the activity you are doing."
The Obama administration announced a new policy on Wednesday that will allow many people to renew their existing insurance policies for two more years even though the policies don't provide the comprehensive coverage and consumer protections required by the Affordable Care Act.
Celladon Corp., a biopharmaceutical company focused on the discovery and development of innovative treatments for cardiovascular diseases, today announced that 12-month data from its Phase 2 CUPID clinical trial of MYDICAR demonstrated significant improvements in clinical outcomes and key disease markers in advanced heart failure patients treated with the genetically-targeted enzyme replacement therapy.
RyMed Technologies will host a breakfast symposium on the origin of catheter-related bloodstream infections (CRBSIs) and how to prevent them at the upcoming Annual Scientific Meeting of the Association for Vascular Access (AVA).
› Verified 4 days ago
| Quality Measure | Provider | National Avg. |
|---|---|---|
| How often patients got better at walking or moving around | 96.8 | 79.6 |
| How often patients got better at getting in and out of bed | 87.6 | 81.1 |
| How often patients got better at bathing | 89.6 | 82.3 |
| How often patients’ breathing improved | 95.6 | 82.8 |
| How often patients’ wounds improved or healed after an operation | 91.8 | 92.3 |
| How often patients got better at taking their drugs correctly by mouth | 83.8 | 75 |
| How often home health patients had to be admitted to the hospital | 9.2 | 15.4 |
| How often patients receiving home health care needed urgent, unplanned care in the ER without being admitted | 9.3 | 13 |
| How often physician-recommended actions to address medication issues were completely timely | 98.9 | 94 |
News Archive
"The results of this study are consistent with an American study which found that outdoor sport was protective, however our study shows that the crucial feature is being outdoors irrespective of the activity you are doing."
The Obama administration announced a new policy on Wednesday that will allow many people to renew their existing insurance policies for two more years even though the policies don't provide the comprehensive coverage and consumer protections required by the Affordable Care Act.
Celladon Corp., a biopharmaceutical company focused on the discovery and development of innovative treatments for cardiovascular diseases, today announced that 12-month data from its Phase 2 CUPID clinical trial of MYDICAR demonstrated significant improvements in clinical outcomes and key disease markers in advanced heart failure patients treated with the genetically-targeted enzyme replacement therapy.
RyMed Technologies will host a breakfast symposium on the origin of catheter-related bloodstream infections (CRBSIs) and how to prevent them at the upcoming Annual Scientific Meeting of the Association for Vascular Access (AVA).
› Verified 4 days ago
| Question Type: | Rating by Patients |
|---|---|
| Health team gave care in a professional way | |
| Health team communicated well with them | |
| Health team discussed medicines, pain, and home safety | |
| How patients rated overall care from agency |
News Archive
"The results of this study are consistent with an American study which found that outdoor sport was protective, however our study shows that the crucial feature is being outdoors irrespective of the activity you are doing."
The Obama administration announced a new policy on Wednesday that will allow many people to renew their existing insurance policies for two more years even though the policies don't provide the comprehensive coverage and consumer protections required by the Affordable Care Act.
Celladon Corp., a biopharmaceutical company focused on the discovery and development of innovative treatments for cardiovascular diseases, today announced that 12-month data from its Phase 2 CUPID clinical trial of MYDICAR demonstrated significant improvements in clinical outcomes and key disease markers in advanced heart failure patients treated with the genetically-targeted enzyme replacement therapy.
RyMed Technologies will host a breakfast symposium on the origin of catheter-related bloodstream infections (CRBSIs) and how to prevent them at the upcoming Annual Scientific Meeting of the Association for Vascular Access (AVA).
› Verified 4 days ago
The patient survey data of Assisted Daily Living, Inc. is compared against the national average with the color code indicators: Better than National Average Worse than National Average| Experience Measure | Provider | National Avg. |
|---|---|---|
| Percent of patients who reported that their home health team gave care in a professional way | 84 | 88 |
| Percent of patients who reported that their home health team communicated well with them | 83 | 85 |
| Percent of patients who reported that their home health team discussed medicines, pain, and home safety with them | 84 | 83 |
| Percent of patients who gave their home health agency a rating of 9 or 10 on a scale from 0 (lowest) to 10 (highest) | 78 | 84 |
| Percent of patients who reported YES, they would definitely recommend the home health agency to friends and family | 75 | 78 |
News Archive
"The results of this study are consistent with an American study which found that outdoor sport was protective, however our study shows that the crucial feature is being outdoors irrespective of the activity you are doing."
The Obama administration announced a new policy on Wednesday that will allow many people to renew their existing insurance policies for two more years even though the policies don't provide the comprehensive coverage and consumer protections required by the Affordable Care Act.
Celladon Corp., a biopharmaceutical company focused on the discovery and development of innovative treatments for cardiovascular diseases, today announced that 12-month data from its Phase 2 CUPID clinical trial of MYDICAR demonstrated significant improvements in clinical outcomes and key disease markers in advanced heart failure patients treated with the genetically-targeted enzyme replacement therapy.
RyMed Technologies will host a breakfast symposium on the origin of catheter-related bloodstream infections (CRBSIs) and how to prevent them at the upcoming Annual Scientific Meeting of the Association for Vascular Access (AVA).
› Verified 4 days ago
Vna Of Care New England Location: 51 Health Lane, Warwick, Rhode Island 2886 Ratings: Phone: (401) 737-6050 | |
Assisted Daily Living, Inc. Location: 2809 Post Road, Warwick, Rhode Island 2886 Ratings: Phone: (401) 738-5470 | |
Amedisys Home Health Care Location: 300 Centerville Road, Suite 202 East, Warwick, Rhode Island 2886 Ratings: Phone: (401) 273-2280 | |
Cathleen Naughton Associates Location: 2364 Post Road, Warwick, Rhode Island 2886 Ratings: Phone: (401) 773-7401 | |
Pinnacle Home Care Llc Location: 57 Kilvert Street Suite 105, Warwick, Rhode Island 2886 Ratings: Phone: (401) 921-3133 |